Market Closed -
Other stock markets
|
Pre-market 07:00:41 am | |||
900.2 USD | +0.37% | 893 | -0.80% |
Apr. 17 | UBS Adjusts Regeneron Pharmaceuticals Price Target to $1,099 From $1,090, Maintains Buy Rating | MT |
Apr. 17 | The market is pinning its hopes on earnings reports |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.